Literature DB >> 9292446

Computer-assisted psychotherapy.

J H Wright1, A S Wright.   

Abstract

The rationale for using computers in psychotherapy includes the possibility that therapeutic software could improve the efficiency of treatment and provide access for greater numbers of patients. Computers have not been able to reliably duplicate the type of dialogue typically used in clinician-administered therapy. However, computers have significant strengths that can be used to advantage in designing treatment programs. Software developed for computer-assisted therapy generally has been well accepted by patients. Outcome studies have usually demonstrated treatment effectiveness for this form of therapy. Future development of computer tools may be influenced by changes in health care financing and rapid growth of new technologies. An integrated care delivery model incorporating the unique attributes of both clinicians and computers should be adopted for computer-assisted therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9292446      PMCID: PMC3330466     

Source DB:  PubMed          Journal:  J Psychother Pract Res        ISSN: 1055-050X


  3 in total

1.  Improving Cost-effectiveness and Access to Cognitive Behavior Therapy for Depression: Providing Remote-Ready, Computer-Assisted Psychotherapy in Times of Crisis and Beyond.

Authors:  Michael E Thase; Paul McCrone; Marna S Barrett; Tracy D Eells; Stephen R Wisniewski; G K Balasubramani; Gregory K Brown; Jesse H Wright
Journal:  Psychother Psychosom       Date:  2020-05-12       Impact factor: 17.659

2.  Improving the Efficiency of Psychotherapy for Depression: Computer-Assisted Versus Standard CBT.

Authors:  Michael E Thase; Jesse H Wright; Tracy D Eells; Marna S Barrett; Stephen R Wisniewski; G K Balasubramani; Paul McCrone; Gregory K Brown
Journal:  Am J Psychiatry       Date:  2017-10-03       Impact factor: 18.112

3.  Assessing your mood online: acceptability and use of Moodscope.

Authors:  G Drake; E Csipke; T Wykes
Journal:  Psychol Med       Date:  2012-11-13       Impact factor: 7.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.